# OnCo record gkl-006 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gkl-006/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gkl-006" ;
  schema:name "GKL-006 Injection"@en ;
  schema:alternateName "GKL-006"@en ;
  schema:description "GKL-006 Injection is an experimental autologous iNKT cell therapy from Beijing Gene Key Life Technology, in phase 2 trials for unresectable hepatocellular carcinoma and advanced pancreatic ductal adenocarcinoma."@en ;
  schema:url <https://onco.cc/drugs/gkl-006/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT07845266>, <https://clinicaltrials.gov/api/v2/studies/NCT07209813>, <https://clinicaltrials.gov/api/v2/studies/NCT07777211>, <https://clinicaltrials.gov/search?intr=GKL-006> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Autologous iNKT cell therapy" ;
  onco:cancers <https://onco.cc/cancers/hcc-advanced/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:companies <https://onco.cc/companies/beijing-gene-key-life-technology/> ;
  onco:trials <https://onco.cc/trials/nct07209813/>, <https://onco.cc/trials/nct07777211/>, <https://onco.cc/trials/nct07713290/>, <https://onco.cc/trials/nct07845266/> .